Vanguard Capital Management’s Anixa Biosciences ANIX Stock Holding History
Bought
Maintained
Sold
Other funds holding ANIX
Vanguard Capital Management's ANIX Position: Q3 2026 in Review
Vanguard Capital Management held its Anixa Biosciences (ANIX) position steady in Q3 2026 at 1,329,852 shares worth $3.9M. The position accounts for ﹤0.01% of the portfolio, ranked #3159.
Vanguard Capital Management first reported a position in ANIX in Q1 2026 and has held it in 3 quarters since. 74 funds tracked by Wall St. Rank hold ANIX as of Q3 2026.
- Vanguard Capital Management held 1,329,852 shares of Anixa Biosciences worth $3.9M as of Q3 2026.
- Vanguard Capital Management left its Anixa Biosciences share count unchanged in Q3 2026.
- Anixa Biosciences made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #3159 holding.
- Vanguard Capital Management first reported a position in Anixa Biosciences in Q1 2026 and has held it in 3 quarters since.
- 74 funds tracked by Wall St. Rank held Anixa Biosciences as of Q3 2026.
Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.